Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Johnson and Johnson
Argus Health

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 3,706,789

« Back to Dashboard

Summary for Patent: 3,706,789

Title: PGF .alpha.
Abstract:The prostaglandins PGF.sub.2 .alpha. and PGF.sub.2 .beta., and their salts, esters, and alkanoates are disclosed. These novel compounds are useful for a variety of pharmacological purposes, including use as smooth muscle stimulants and as cardiovascular agents.
Inventor(s): Bergstrom; Sune (Stockholm 60, SW), Sjovall; Jan (Stockholm 60, SW)
Application Number:05/115,111
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 3,706,789

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom12,139/62Mar 29, 1962

International Patent Family for Patent: 3,706,789

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany1160981► Subscribe
Germany1443474► Subscribe
Germany1643738► Subscribe
Germany1643739► Subscribe
Germany1643740► Subscribe
Denmark126106► Subscribe
Denmark129336► Subscribe
Denmark130067► Subscribe
Denmark131462► Subscribe
United Kingdom851827► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus